These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


369 related items for PubMed ID: 6140032

  • 1. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME, Chevesich J, Lehrer E, Mosnaim AD.
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987 Oct; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD.
    Can Med Assoc J; 1982 Mar 01; 126(5):468. PubMed ID: 6121618
    [No Abstract] [Full Text] [Related]

  • 6. [Prevention of tardive dyskinesia caused by neuroleptic therapy].
    Perényi A.
    Orv Hetil; 1981 Jul 05; 122(27):1627-30. PubMed ID: 6117046
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R, Kay SR.
    Funct Neurol; 1991 Jul 05; 6(2):151-7. PubMed ID: 1680777
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE, Povlsen UJ, Meidahl B, Gerlach J.
    Psychopharmacol Bull; 1986 Jul 05; 22(1):250-3. PubMed ID: 2873612
    [No Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia and the primary psychiatric diagnosis.
    Yassa R, Nair V, Schwartz G.
    Psychosomatics; 1984 Feb 05; 25(2):135-8. PubMed ID: 6142494
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM.
    J Am Geriatr Soc; 2004 Dec 05; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr 05; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A five year follow-up study of tardive dyskinesia.
    Chouinard G, Annable L, Mercier P, Ross-Chouinard A.
    Psychopharmacol Bull; 1986 Apr 05; 22(1):259-63. PubMed ID: 2873614
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.